These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23902589)

  • 1. Comparison of mailed invitation strategies to improve fecal occult blood test participation in men: protocol for a randomized controlled trial.
    Duncan A; Zajac I; Flight I; Stewart BJ; Wilson C; Turnbull D
    Trials; 2013 Jul; 14():239. PubMed ID: 23902589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theory-based modifications of an advanced notification letter improves screening for bowel cancer in men: A randomised controlled trial.
    Zajac IT; Duncan AC; Flight I; Wittert GA; Cole SR; Young GP; Wilson CJ; Turnbull DA
    Soc Sci Med; 2016 Sep; 165():1-9. PubMed ID: 27485727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An advance notification letter increases participation in colorectal cancer screening.
    Cole SR; Smith A; Wilson C; Turnbull D; Esterman A; Young GP
    J Med Screen; 2007; 14(2):73-5. PubMed ID: 17626705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two randomized controlled trials for colorectal cancer screening invitations developed using a behavioral science approach.
    Tinmouth J; Llovet D; Sutradhar R; Tsiplova K; Roushani J; Lee A; Hader J; Rabeneck L; Paszat L
    Prev Med; 2022 Feb; 155():106918. PubMed ID: 34953810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
    Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
    Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using physician-linked mailed invitations in an organised colorectal cancer screening programme: effectiveness and factors associated with response.
    Tinmouth J; Baxter NN; Paszat LF; Rabeneck L; Sutradhar R; Yun L
    BMJ Open; 2014 Mar; 4(3):e004494. PubMed ID: 24622950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial.
    Regge D; Iussich G; Senore C; Correale L; Hassan C; Bert A; Montemezzi S; Segnan N
    Trials; 2014 Mar; 15():97. PubMed ID: 24678896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders.
    Tinmouth J; Patel J; Austin PC; Baxter NN; Brouwers MC; Earle C; Levitt C; Lu Y; Mackinnon M; Paszat L; Rabeneck L
    Int J Cancer; 2015 Mar; 136(6):E697-703. PubMed ID: 25195923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program.
    Wood A; Emery JD; Jenkins M; Chondros P; Campbell T; Wenkart E; O'Reilly C; Cowie T; Dixon I; Toner J; Khalajzadeh H; Gutierrez JM; Govan L; Buckle G; McIntosh JG
    Trials; 2022 Jan; 23(1):31. PubMed ID: 35022080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study).
    Sali L; Grazzini G; Carozzi F; Castiglione G; Falchini M; Mallardi B; Mantellini P; Ventura L; Regge D; Zappa M; Mascalchi M; Milani S
    Trials; 2013 Mar; 14():74. PubMed ID: 23497601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARTERscreen protocol: a three-arm cluster randomised controlled trial of patient SMS messaging in general practice to increase participation in the Australian National Bowel Cancer Screening Program.
    McIntosh JG; Emery JD; Wood A; Chondros P; Goodwin BC; Trevena J; Wilson C; Chang S; Hocking J; Campbell T; Macrae F; Milley K; Lew JB; Nightingale C; Dixon I; Castelli M; Lee N; Innes L; Jolley T; Fletcher S; Buchanan L; Doncovio S; Broun K; Austin G; Jiang J; Jenkins MA
    Trials; 2023 Nov; 24(1):723. PubMed ID: 37957680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invitation strategies for colorectal cancer screening programmes: The impact of an advance notification letter.
    Senore C; Ederle A; DePretis G; Magnani C; Canuti D; Deandrea S; Zorzi M; Barca A; Bestagini P; Faitini K; Bisanti L; Casale C; Ferro A; GiorgiRossi P; Quadrino F; Fiorina G; Capuano A; Segnan N; Fantin A
    Prev Med; 2015 Apr; 73():106-11. PubMed ID: 25602908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
    BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.
    Benito L; Travier N; Binefa G; Vidal C; Espinosa J; Milà N; Garcia M
    Cancer Prev Res (Phila); 2019 May; 12(5):327-334. PubMed ID: 30890542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative evaluation of strategies to increase colorectal cancer screening uptake.
    Tinmouth J; Ritvo P; McGregor SE; Claus D; Pasut G; Myers RE; Guglietti C; Paszat LF; Hilsden RJ; Rabeneck L
    Can Fam Physician; 2011 Jan; 57(1):e7-15. PubMed ID: 21322288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use.
    Santare D; Kojalo I; Huttunen T; Rikacovs S; Rucevskis P; Boka V; Leja M
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):536-43. PubMed ID: 25806603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial.
    Hewitson P; Ward AM; Heneghan C; Halloran SP; Mant D
    Br J Cancer; 2011 Aug; 105(4):475-80. PubMed ID: 21829202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Text messaging as a tool to improve cancer screening programs (M-TICS Study): A randomized controlled trial protocol.
    Vives N; Farre A; Ibáñez-Sanz G; Vidal C; Binefa G; Milà N; Pérez-Lacasta MJ; Travier N; Benito L; Espinàs JA; Bagaria G; Garcia M
    PLoS One; 2021; 16(1):e0245806. PubMed ID: 33481914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.